In a normally developing 3‑year‑old child, can intramuscular vaccines be administered in the deltoid muscle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Deltoid Injections in 3-Year-Olds

Yes, intramuscular vaccines can be administered in the deltoid muscle of a normally developing 3-year-old child, provided the child has adequate deltoid muscle mass on visual and manual assessment. 1

Age-Based Site Selection

For children ≥12 months through 18 years, the deltoid becomes an acceptable primary injection site once adequate muscle mass is present. 1 Since your patient is 3 years old, they fall well within this age range where deltoid use is appropriate. 2, 1

  • The anterolateral thigh was the preferred site for infants <12 months because it provides the largest muscle mass in that age group. 1
  • After 12 months of age, the deltoid transitions to become an acceptable and often preferred site. 2, 1
  • The anterolateral thigh remains an alternative option if deltoid muscle mass is insufficient. 1

Critical Assessment Required

You must visually and manually palpate the deltoid to assess muscle bulk before selecting this site—do not assume all 3-year-olds have adequate deltoid development. 1 This individual assessment is required for each child. 1

  • If the deltoid appears underdeveloped on examination, continue using the anterolateral thigh even though the child is past 12 months of age. 1
  • Research using ultrasound measurements confirms that by 25-36 months, deltoid muscle thickness averages 9.28 mm, which is adequate for intramuscular injection. 3

Proper Needle Specifications for a 3-Year-Old

Use a 22-25 gauge needle that is 7/8 inch to 1¼ inches long for deltoid injections in children ≥12 months. 2, 1 The needle length should be selected based on the individual child's muscle bulk. 1

  • The needle must be long enough to reach the muscle tissue and prevent medication from seeping into subcutaneous tissue. 2, 4
  • Using needles that are too short results in subcutaneous rather than intramuscular delivery, which reduces vaccine efficacy and increases local reactions. 1

Injection Technique

Insert the needle at a 90-degree angle perpendicular to the skin surface. 2, 1 This angle is critical because deviating from it can reduce medication efficacy or increase local adverse reactions. 2

  • When administering multiple injections in the same limb, separate injection sites by more than 1 inch to allow clear differentiation of local reactions. 2, 1
  • Never inject into the gluteal region due to risk of sciatic nerve injury and decreased vaccine immunogenicity. 1, 4

Common Pitfalls to Avoid

Do not assume universal deltoid adequacy without performing a visual and manual assessment of muscle bulk. 1 This is the most common error when transitioning from thigh to deltoid injections in toddlers.

  • Avoid using the deltoid routinely before 12 months of age, as the thigh provides more reliable muscle mass in infants. 1
  • Do not use inadequate needle length for the patient's body size, as this results in subcutaneous delivery. 1

References

Guideline

Guidelines for Deltoid Intramuscular Vaccination Across Age Groups

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Intramuscular Injection Technique

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Injection Techniques and Needle Sizes for Various Age Groups and Injection Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.